Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer

PURPOSE: We examined in a prospective, randomized, international clinical trial the performance of a previously defined 30-gene predictor (DLDA-30) of pathologic complete response (pCR) to preoperative weekly paclitaxel and fluorouracil, doxorubicin, cyclophosphamide (T/FAC) chemotherapy, and assess...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tabchy, Adel, Valero, Vicente, Vidaurre, Tatiana, Lluch, Ana, Gomez, Henry, Martin, Miguel, Qi, Yuan, Barajas-Figueroa, Luis Javier, Souchon, Eduardo, Coutant, Charles, Doimi, Franco D, Ibrahim, Nuhad K, Gong, Yun, Hortobagyi, Gabriel N, Hess, Kenneth R, Symmans, W Fraser, Pusztai, Lajos
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4181852/
https://ncbi.nlm.nih.gov/pubmed/20829329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-1265
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky